| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Palisade Bio, Inc. (PALI) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. PALI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 9.18M | $17.17M | - | |
| Other | 7.67M | $14.34M | - | |
| Dir | 1.51M | $2.82M | - | |
| Dir | 613.4K | $1.15M | - | |
| Dir | 592.3K | $1.11M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2016 | Daly Richard J | Chief Executive Officer | Buy | 31,250 | $0.32 | $10,000.00 | New | |
| Nov 16, 2015 | Johe Karl | Chief Scientific Officer | Sell | 25,000 | $1.09 | $27,250.00 | -2.9% | |
| Nov 9, 2015 | Johe Karl | Chief Scientific Officer | Sell | 25,000 | $1.18 | $29,500.00 | -2.9% | |
| Nov 2, 2015 | Johe Karl | Chief Scientific Officer | Sell | 25,000 | $1.17 | $29,355.00 | -2.8% | |
| Oct 26, 2015 | Johe Karl | Chief Scientific Officer | Sell | 25,000 | $1.13 | $28,190.00 | -2.7% | |
| Oct 19, 2015 | Johe Karl | Chief Scientific Officer | Sell | 25,000 | $1.23 | $30,690.00 | -2.6% | |
| Oct 12, 2015 | Johe Karl | Chief Scientific Officer | Sell | 25,000 | $1.31 | $32,725.00 | -2.6% | |
| Oct 5, 2015 | Johe Karl | Chief Scientific Officer | Sell | 25,000 | $1.26 | $31,460.00 | -2.5% | |
| Sep 28, 2015 | Johe Karl | Chief Scientific Officer | Sell | 25,000 | $1.64 | $41,000.00 | -2.4% | |
| Sep 21, 2015 | Johe Karl | Chief Scientific Officer | Sell | 25,000 | $1.52 | $38,077.50 | -2.4% |